You have been told you need a total knee replacement. Get the sports and regenerative medicine answer before you commit. Many of our most successful cases arrive exactly here, told surgery is the only option, looking for an alternative. A significant proportion do exceptionally well with the Dynamic Athlete sports and regenerative medicine protocol: Dynamic Stem Cell+ combined with focused electromagnetic shockwave and EMTT, even with bone-on-bone changes. The goal is meaningful pain relief, restored function, and a knee you keep for years. This is sports and regenerative medicine built for the surgery avoider.
Knee replacement is irreversible. Biology is not. Before you commit to the surgical pathway, find out whether your knee is one of the many that responds to the right sports and regenerative medicine combination.
The Short Answer
Most patients who have been told they need a total knee replacement do not need it yet, and many never need it. The Dynamic Athlete sports and regenerative medicine protocol (Dynamic Stem Cell+ (autologous bone marrow or adipose-derived stem cells with high-dose PRP and exosome FRP, plus focused electromagnetic shockwave and EMTT for the subchondral bone and peri-articular tissue) routinely delivers meaningful pain relief and function for moderate-to-advanced arthritis, including bone-on-bone changes. This is the sports and regenerative medicine pathway built specifically for the surgery avoider.
A small number of cases with severe deformity, mechanical instability, or true end-stage destruction will eventually need surgery. We tell you which category you are in. The default posture is try regenerative first; the honest posture is refer when surgery is genuinely warranted. Over 90% of our patients self-report a 75% or greater improvement, all without surgery.
Key Takeaways
- Knee replacement is irreversible. Biology is not. Exhaust the regenerative pathway before committing to surgery you cannot undo.
- Bone-on-bone on imaging is not always bone-on-bone on the joint surface. Many patients told they need replacement are not as advanced as the imaging makes them look.
- The Dynamic Stem Cell+ combined protocol (autologous BMA or MFAT with high-dose PRP and exosome FRP, plus focused shockwave and EMTT) is built specifically for moderate-to-advanced and bone-on-bone arthritis.
- Over 90% of our patients self-report a 75% or greater improvement, including patients with bone-on-bone changes.
- The regenerative pathway is significantly less expensive than surgery when you count the full cost (surgical center, anesthesia, weeks of rehab, time off work, potential revision in 15-20 years).
- HSA and FSA dollars typically apply, and Cherry financing lets you spread the investment over monthly payments. Cost should not be the reason you accept a recommended surgery.
- If surgery is genuinely the right call, we tell you and we coordinate. A clinic that never recommends surgery is not making clinical decisions.
Why this is actually a real alternative?
Most “alternatives to knee replacement” marketed in the Front Range are either single-modality regenerative care (PRP alone, or stem cell alone), or non-autologous donor products (amniotic, umbilical cord). Neither is built for advanced knee arthritis. The Dynamic Stem Cell+ combined protocol is. Here is the six-part case for why this works where simpler protocols often fail.
01. The combined protocol, not single modality
Advanced knee arthritis lives in more than one tissue at the same time: cartilage, subchondral bone, peri-articular soft tissue, joint capsule, tendons. A protocol that treats only the joint space leaves the surrounding pain drivers untreated. Dynamic Stem Cell+ combines autologous stem cells with high-dose PRP and exosome FRP for the intra-articular space, plus focused electromagnetic shockwave and EMTT for the subchondral bone and peri-articular soft tissue. Every pain driver gets addressed in one protocol.
02. Autologous, FDA-compliant, NOT amniotic or cord
Dynamic Stem Cell+ uses cells from your own body: bone marrow aspirate (BMA) from the iliac crest or microfragmented adipose tissue (MFAT) from subcutaneous fat. Same-day, minimally manipulated, performed within the FDA framework for autologous cell procedures (21 CFR 1271). No amniotic, no umbilical cord, no Wharton’s jelly products. No cultured or expanded cells. No offshore protocols. The FDA has issued warning letters to clinics offering those. This is a different procedure.
03. Performed personally by Dr. Garg under live ultrasound
Every Dynamic Stem Cell+ at Dynamic Athlete is performed by Dr. Aneesh Garg, DO, CAQ personally. Every harvest, every injection. Live ultrasound guidance at every visit. Shockwave and EMTT sessions are delivered by Dr. Garg and his trained clinical team under protocols he authors and reviews. The physician with the training is the one with the needle in their hand for the part of the procedure where targeting and depth decide outcomes.
04. Built for moderate, advanced, and bone-on-bone
Rigorous studies show similar 12-24 month outcomes for PRP and stem cell therapy in mild-to-moderate knee osteoarthritis, so PRP is often the right first step for early disease. The stem cell advantage becomes visible in more advanced disease, where PRP alone may not deliver sustained benefit. Dynamic Stem Cell+ is specifically built for moderate-to-advanced and bone-on-bone knee arthritis, the patients who have been told they need replacement.
05. Cheaper than the surgical pathway, with Cherry financing available
When you count the full cost (surgical center fees, anesthesia, implant cost, weeks to months of structured rehabilitation, time off work, and the potential revision surgery 15 to 20 years later), the regenerative pathway is significantly less expensive than total knee replacement for most patients. HSA and FSA dollars typically apply, and Cherry financing lets patients spread the investment over monthly payments (soft credit check, no FICO impact). Cost should not be the reason you accept a surgical recommendation when the regenerative answer is workable.
06. If surgery is genuinely the answer, we coordinate. We don’t waste your time.
A clinic that never recommends surgery is not making clinical decisions. Some knees genuinely need surgery: end-stage destruction with severe deformity, mechanical instability, true persistent disabling pain after a fair regenerative trial. We tell you when that is your case, and we coordinate directly with trusted orthopedic surgical colleagues in the Boulder and Denver area. If anything, optimizing the peri-articular tissue with shockwave and EMTT before surgery may improve surgical recovery. The default is try regenerative first; the honest answer is refer when warranted.
When the alternative works, and when it doesn’t?
The table below shows the honest decision tree. Most patients told they need replacement fall into the “regenerative first” rows.
Moderate knee OA, told to consider replacement
| Patient profile | Regenerative first | Surgical evaluation |
|---|---|---|
| Yes (start here) | Reassess if regenerative fails | |
| Bone-on-bone on imaging, without severe deformity or instability | Yes (start here) | Reassess if response inadequate |
| Bone-on-bone with mild deformity, active patient who wants to keep knee | Yes (start here) | Coordinated approach |
| Prior partial PRP response, advanced disease, surgery proposed | Yes (escalate to Stem Cell+) | If escalation fails |
| Surgery delayed by personal circumstances, looking to keep working | Yes (buy time with quality) | When circumstances change |
| End-stage destruction plus severe deformity (varus/valgus > 15°) | Adjunct, not replacement | Yes (surgical evaluation) |
| Mechanical instability, locking, displaced fracture | Post-op adjunct only | Yes (surgical evaluation) |
| Failed multiple regenerative trials plus persistent disabling pain | No (escalation has been honest) | Yes (surgical evaluation) |
The Honest Posture
We tell you when surgery is the right answer. The default is regenerative first because it is reversible, less expensive, lower-risk, and routinely effective even for advanced disease. The exception is when the knee is genuinely past the point where regenerative care can deliver. You leave the consult with a candid yes, no, or staged plan, not a sales pitch.
Frequently asked questions?
A second opinion before surgery, from the physician who will tell you when not to do it
How to evaluate any clinic for a knee procedure, and our answers
If you have been told you need a knee replacement, bring your imaging. Dr. Garg reviews it himself and tells you what he sees: whether a non-surgical option fits your knee, whether surgery is the right answer, or whether our procedures are the wrong ones for you. Below are seven questions to put to any clinic before a knee procedure, with our answers.
1. Who performs the injection?
Aneesh Garg, DO, CAQ, performs every PRP and stem cell injection personally. He is double board-certified in Sports Medicine and Internal Medicine, and injections are not delegated to assistants or technicians.
2. Is the injection placed under live imaging?
Yes. Every PRP and stem cell injection is placed under live ultrasound, so the needle is watched reaching the target tissue.
3. What exactly is in the syringe?
PRP is prepared from your own blood in multiple spins, and our Dynamic PRP+ protocol is designed to concentrate platelets 12 to 20 times baseline, over 10 billion platelets, with exosome-containing fibrin-rich plasma (FRP). Stem cell procedures use your own bone marrow aspirate (BMA) or micro-fragmented adipose tissue (MFAT), selected by the physician for the tissue being treated, and these cells are most accurately called mesenchymal signaling cells. Nothing comes from a donor.
4. Who is a candidate, and who do you turn away?
We screen before we schedule, and some people are not candidates: a complete structural tear that needs surgical repair, an active infection, or certain cancers generally rules out an injection. Severe deformity, gross instability, or a locked or mechanically blocked knee may call for surgical evaluation first, and we tell you which category you are in after imaging and diagnostic ultrasound. If surgery is the right answer, I will tell you.
5. What does the evidence say?
A 2025 systematic review of six randomized trials in mild-to-moderate knee osteoarthritis, comparing PRP with hyaluronic acid, corticosteroid or placebo, concluded that PRP gave significant short- to mid-term improvements in pain and function with a favorable safety profile, while evidence of structural benefit remains limited and results are not uniformly superior to placebo. A 2026 network meta-analysis of 56 randomized trials concluded that PRP is effective for knee osteoarthritis but that its findings do not support a “more is better” approach to platelet and leukocyte enrichment, and an AAOS technology overview of studies through August 2021, which makes no recommendation for or against PRP, states that the optimal preparation and products remain to be determined. Each calls for further, larger or better-designed trials. Sources: Nawaz et al., Cureus 2025 (https://doi.org/10.7759/cureus.94288); Anitua et al., Knee Surgery & Related Research 2026 (https://doi.org/10.1186/s43019-026-00318-4); AAOS Technology Overview, PRP for Knee Osteoarthritis (https://www.aaos.org/globalassets/quality-and-practice-resources/biologics/technology-overview_prp-for-knee-oa.pdf).
6. How are results tracked?
We track patient-reported outcomes in practice. Separately, we run retrospective studies approved by the Rocky Vista University IRB.
7. What does it cost?
We give a quote after a thorough evaluation, and we price the plan for optimal outcomes, not line items off a menu. Every patient leaves with a good understanding of the next steps. PRP and stem cell procedures are out of pocket, and Cherry financing is available.
Is there an alternative to total knee replacement?
For most patients, yes. Many of our most successful arthritis cases arrive after a surgical consultation, told they need a total knee replacement, looking for an alternative. The Dynamic Stem Cell+ combined protocol (autologous bone marrow or adipose-derived BMA and MFAT stem cell therapy with high-dose PRP and exosome FRP, plus focused electromagnetic shockwave and EMTT for the subchondral bone and peri-articular tissue) frequently delivers meaningful pain relief, restored function, and a knee the patient keeps using for years. Even patients with bone-on-bone changes routinely respond. A small number of cases with severe deformity, mechanical instability, or end-stage destruction will eventually need surgical intervention, and we coordinate with orthopedic surgeons in the Boulder and Denver area when that is the right call. The default posture at Dynamic Athlete is to try the regenerative pathway first.
Can stem cell therapy help bone-on-bone knee arthritis?
Yes, in many cases. Bone-on-bone on imaging is not always bone-on-bone on the joint surface, and the patient experience varies more than the imaging suggests. Dynamic Stem Cell+ combines autologous BMA or MFAT stem cells with high-dose PRP and exosome FRP, delivered under live ultrasound by Dr. Aneesh Garg, DO, CAQ personally. Combined with focused electromagnetic shockwave and EMTT for the subchondral bone and peri-articular tissue, the protocol frequently delivers meaningful pain relief and extends knees by years. Over 90% of our patients self-report a 75% or greater improvement, all without surgery.
How successful is the alternative to knee replacement at Dynamic Athlete?
Over 90% of our patients self-report a 75% or greater improvement, all without surgery. For knee arthritis, our combined protocol is Dynamic Stem Cell+: your own bone marrow aspirate (BMA) or micro-fragmented adipose tissue (MFAT), with Dynamic PRP+ designed to concentrate platelets 12 to 20 times baseline (over 10 billion platelets) and exosome-containing fibrin-rich plasma added when it makes sense for your knee, placed under live ultrasound by Dr. Garg personally; focused shockwave and EMTT can treat the surrounding tissue.
When do I actually need a knee replacement?
True surgical indication is reserved for the patient with end-stage bone-on-bone destruction plus severe deformity, mechanical instability, or persistent disabling pain after a fair trial of the regenerative pathway. Severe varus or valgus deformity, gross instability, locking, mechanical block, or large meniscus root tears in younger patients may warrant earlier surgical evaluation. We tell you which category you are in at the consult, after imaging and point-of-care diagnostic ultrasound. A clinic that never recommends surgery is not making clinical decisions; we refer when surgery is genuinely the right call.
How is the regenerative alternative cheaper than a knee replacement?
When you count the full cost, the regenerative pathway is significantly less expensive than the surgical pathway for most patients. Total knee replacement involves surgical center fees, anesthesia, implant cost, weeks to months of structured rehabilitation, time off work, and potential revision surgery 15-20 years later. The regenerative course at Dynamic Athlete is delivered in office, no anesthesia, no recovery period, and typically no time off work. For patients staging off or avoiding replacement, the regenerative investment frequently pays for itself in lost-income avoidance alone. HSA and FSA dollars typically apply, and Cherry financing lets patients spread the investment over monthly payments.
What does the alternative to knee replacement protocol look like?
Consult with imaging review and point-of-care diagnostic ultrasound. Staged Dynamic Stem Cell+ injection under live ultrasound (autologous BMA or MFAT combined with high-dose PRP and exosome FRP), performed by Dr. Garg personally. Focused electromagnetic shockwave and EMTT for the subchondral bone and peri-articular tissue, typically over three to six sessions with continuous evaluation of progress. Reassessment over weeks. The protocol is built from your imaging, your stage of disease, and your goals. Some patients respond fully to the first injection; others benefit from a second injection or escalation.
What if the regenerative pathway does not work for me?
We coordinate directly with trusted orthopedic surgical colleagues in the Boulder and Denver area when surgery is the right call. The regenerative attempt does not foreclose surgical options; if anything, optimizing the peri-articular tissue with shockwave and EMTT before surgery may improve surgical recovery. We tell you honestly when a knee is past the point where regenerative care can deliver. A clinic that never recommends surgery is not making clinical decisions.
Will I qualify if I have been told my knee is bone-on-bone?
It depends, and we tell you at the consult. Imaging severity and symptoms do not always match, so Dr. Garg reviews your imaging himself and examines the knee with diagnostic ultrasound before he says whether an injection-based approach fits. Advanced bone-on-bone disease is sometimes better served by other options, and if surgery is the right answer, we will say so. Cherry financing is available for PRP and stem cell procedures.